Search

everythinglearnresearchcommunity

for

Search:↓

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Fzd2 is important for skin and hair development through various signaling ways.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

New treatments for sudden hair loss include oral medications and a special laser, both showing promise in hair regrowth.

Baricitinib is effective and safe for treating severe alopecia areata.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

An elderly Chinese man lost all his hair after taking a new heart medication.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

OR-101 shows promise for treating alopecia areata by improving hair growth.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Aging causes skin stem cells to work less effectively.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.